Wagner AG » Molecular Microbiology (Virology)

University of Regensburg

Institute of Medical Microbiology and Hygiene

Molecular Microbiology (Virology)

Universität Regensburg

Prof. Dr. Ralf Wagner

Legal info


 

  • RESEARCH-BACKGROUND
  • RESEARCH-PROJECTS
    • Running Projects
    • Past Projects
      • RepliVax
      • Hector-2
      • EVAC
      • Tri-LEMvac
      • SynPeptide
      • CUT'HIVAC
      • ForBIMed
      • VDAC
      • PTVDC
      • Hector-1
      • ForProtect
      • SynMod
      • GerontoShield
      • IAVI
  • PUBLICATIONS
  • LECTURES
  • MEETINGS & EVENTS
  • NEWS & PRESS
  • TEAM
  • JOBS
  • NETWORKING
  • CONTACT
WHO

Past Projects

  • RepliVax: A Novel Replication Competent Flavivirus-based HIV Vaccine Platform, ie RepliVax®, as a Priming Component for Improving Antibody Response

  • Hector-2: Influence of HIV's glycan shield on the function and longevity of vaccine-induced immune responses

  • EVAC: Emerging Viral Vaccine Antigen Insert Consortium

  • Tri-LEMVac: Trivalent Lassa, Ebola and Marburg viral vaccine

  • SynPeptide: Synthetic Biology for the Design and Production of Antibiotic Peptides

  • CUT'HIVAC: Innovative design of HIV vaccines and delivery systems for transcutaneous immunization

  • ForBIMed: Recombinant Polypeptides with Optimized T-Cell-Activating Properties

  • VDAC: Lentiviral display to screen for improved Env immunogens

  • PTVDC: Poxvirus T Cell Vaccine Discovery Consortium

  • Hector: Mechanisms of the immunological control of HIV replication in LTNP and HIV vaccine candidates derived thereof

  • ForProtect: Computer-assisted design, production and analysis of HIV-specific T-cell immunogens

  • SynMod: Synthetic Biology to Obtain Novel Antibiotics and Optimized Production Systems

  • GerontoShield: Systems biology-driven approach to unravel and revert the mechanisms responsible for poor immune responses in the elderly

  • IAVI: Design of soluble envelope proteins with enhanced trimer stability